Summary

The rising number of elderly people and the prevalence of chronic diseases across Europe are driving demand for home healthcare and fueling European market expansion. The aging population is a major driver of industry growth. The European Union has approved a variety of reimbursement policies for patients. Outpatient care expenditures in Europe are covered by government-mandated financing schemes, driving the market expansion of home healthcare. In many circumstances, most European countries provide free outpatient specialists and basic care. All of the European government's reimbursement policies are predicted to stifle the expansion of the European home healthcare industry. Furthermore, rising awareness of home care services and the introduction of novel equipment for treating various ailments at home are driving market expansion. The development of portable technologies such as heart rate monitors, breathing assistance, and blood glucose monitors has increased the efficiency and effectiveness of lifestyle disease home care. With the transition from inpatient to outpatient care, government reimbursement is also boosting the market for home care in Europe. The government and obligatory financing schemes pay for more than three-quarters of outpatient care costs in the EU. Outpatient specialty and primary care are often free at the point of use in the majority of EU countries. A number of European countries have universal long-term care insurance. Furthermore, the tax-based system in England focuses on providing patients with rehabilitation and rehabilitation services. These factors are projected to drive profitable growth in the European market throughout the forecast period.

According to the research report "Europe Home Healthcare Market Outlook, 2028," published by Bonafide Research, the Europe Home Healthcare market is expected to add more than USD 35 Billion from 2023 to 2028. Unlike many other regions of the world, the majority of European countries provide universal healthcare, with different degrees of coverage for home healthcare services. This translates to a greater reach and the possibility of financial sustainability. Funding models differ greatly. Countries such as Scandinavia rely significantly on government support, while others, such as Germany, have a healthy private insurance market. This creates a dynamic in which factors such as money and insurance coverage can influence access and quality. The landscape of healthcare providers is diverse. Nurses, social workers, and specialist care professionals such as physiotherapists may work for the government, private agencies, or as self-employed individuals. Europe has a wide range of healthcare systems, from wholly public-funded systems (such as the UK's National Health Service) to mixed public-private systems (such as Germany and France) and primarily private systems (such as Switzerland). This diversity has an impact on the availability and accessibility of home healthcare services throughout the continent. Europe has one of the oldest populations on the planet. As a result, there is an increasing emphasis on home healthcare to assist the elderly in managing chronic diseases and challenges associated with aging. This has resulted in greater investment in home-based care services and technologies. The cultural diversity of Europe has an impact on home healthcare methods. Cultural attitudes toward family engagement in caregiving, end-of-life care, and the use of alternative or traditional medicine alongside standard therapies differ by region.

Among all the countries covered in the report, Germany accounts for the largest market for home healthcare in Europe.

The German home healthcare business has seen enormous growth and development in recent years, reflecting the changing needs of an aging population and advances in healthcare technology. Germany, known for its strong healthcare system, has changed its emphasis toward home-based care in order to address the growing demand for personalized and convenient healthcare services. The elderly population in Germany has been a driving force in the expansion of the home healthcare industry. As a greater proportion of the population reaches old age, there is a greater demand for specialized care that allows people to get medical attention and assistance in the comfort of their own homes. This approach not only saves money, but it also improves patients overall health and quality of life. Germany has emerged as a pioneer in home healthcare, developing a distinctive tapestry of qualities that contribute to its success. In the German healthcare system, primary care and preventative measures are prioritized, with a network of general practitioners (Hausärzte) serving as the patient's initial point of contact. This enables early detection and intervention, decreasing the need for more extensive home healthcare later on. The statutory health insurance system in Germany covers nursing care, medical supplies, and assistive technology. Individuals are encouraged to seek medical care from the comfort of their own homes as a result of this financial security. In Germany, the expenditure on home care is balanced between the statutory health insurance system and the social care system, ensuring financial sustainability and minimizing reliance on private funding.

Based on product and services segment market is divided into therapeutic, TSM, mobility and services. Among them Therapeutic product segment is expected to lead the Europe home healthcare market in upcoming time frame.

Europe's population is quickly aging, resulting in an increase in chronic illnesses and age-related health difficulties. Therapeutic products, such as pharmaceuticals, wound care supplies, mobility aids, and medical gadgets for chronic illness management, address the needs of this expanding group. Diabetes, cardiovascular disease, and respiratory disorders are common chronic diseases in Europe. Therapeutic products like insulin, heart drugs, respiratory assistance, and specialist equipment for managing these illnesses are expected to remain in high demand. There has been a noticeable shift toward providing healthcare services at the convenience of one's own home. This trend is being driven by patient preference, cost-effectiveness, and technological improvements that permit remote monitoring and self-care. Therapeutic goods that enable home-based care are thus expected to remain in high demand. Medical technology improvements are resulting in the development of increasingly sophisticated and user-friendly therapeutic items. Wearable health monitoring gadgets, telemedicine solutions, and smart healthcare technologies are enabling improved management of health issues at home, fueling the segment's growth. The emphasis on holistic care encompasses not only medical interventions but also home rehabilitation and palliative care. This increases the demand for therapeutic goods that aid in the delivery of complete treatment outside of typical healthcare facilities.

Cardiovascular disorders and hypertension and cancer are major indication of home healthcare demand in Europe and anticipated to play significant role in development of Europe home healthcare market during the forecast period.

Cardiovascular problems, such as heart disease and stroke, as well as hypertension and cancer, are major public health concerns in Europe. Because these disorders affect a large proportion of the population, there is a strong demand for ongoing care and management. Europe's population is rapidly aging, and age is a major risk factor for cardiovascular disease, hypertension, and some types of cancer. As the aged population grows, so does the prevalence of these disorders, fueling the demand for home-based care for chronic disease management in older persons. Patients increasingly prefer to receive care at home rather than in hospitals or other institutional settings. This preference for home-based treatment is especially prevalent among people living with chronic diseases such as cardiovascular disease, hypertension, and cancer, where personalized care and comfort are crucial. Technological advancements, including remote monitoring devices, wearable sensors, telemedicine platforms, and home-based diagnostic tools, have significantly improved the feasibility of managing these conditions at home. These technologies allow for real-time monitoring, early detection of complications, and timely intervention, contributing to the growth of home healthcare for these indications.

Companies Covered in this report:

Novo Nordisk A/S, Sanofi S.A, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, Baxter International Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Abbott Laboratories, Koninklijke Philips N.V.

Considered in this report:

• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Europe Home Healthcare market Outlook with its value and forecast along with its segments
• Country-wise Home Healthcare market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product and Services:

• Therapeutic
• TSM
• Mobility
• Services

By Indication:

• Cardiovascular Disorders & Hypertension
• Cancer
• Diabetes
• Respiratory Diseases
• Movement Disorders
• Pregnancy
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Home Healthcare industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents